Investors are deploying less capital in biotech startups as a cloudy market outlook and a dearth of IPOs hobble the sector.
Source link
Venture Interest Slackens in Once-Hot Biotech
Related Posts
The First Atomic Bomb Test in 1945 Created an Entirely New Material
In the course of the Trinity nuclear test on July 16, 1945, within the New Mexico desert—the world’s very first…
OpenAI Limits Access to New Model, Citing Government Security Concerns
The corporate mentioned a White Home evaluation of AI releases shouldn’t develop into the norm. Source link
AI’s Real Bottleneck Is Power, Not Compute
As AI demand accelerates, infrastructure limits are rising as the actual bottleneck. Energy, cooling, and provide chains now form deployment…